Trial Profile
Antiplatelet Efficacy of Long-Term Treatment With Clopidogrel Besylate in Patients With a History of Acute Coronary Syndrome: Comparison With Clopidogrel Hydrogen Sulfate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2012
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Acute coronary syndromes; Thrombosis
- Focus Pharmacodynamics
- 06 Jan 2012 New trial record